Occupational Therapists in Spotsylvania, VA Accepting Medicare
5 Occupational Therapists found. Showing 1 - 5
 Kathryn Dick Occupational Therapist - Physical Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6409 Southridge Ct, Spotsylvania, VA 22553 Phone: 540-903-6000 |
Melissa Sullivan Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6929 N Roxbury Mill Rd, Spotsylvania, VA 22551 Phone: 540-582-7600 |
 Matthew Hall Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10212 Ravenscourt Dr Apt 207, Spotsylvania, VA 22553 Phone: 434-390-9511 |
Ellen Crane, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6601 Smith Station Rd, Spotsylvania, VA 22553 Phone: 540-898-5422 |
Cindy Lou Brown, OT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7240 Snow Hill Dr, Spotsylvania, VA 22551 Phone: 540-710-3271 |
News Archive
Lancet World Report examines health risks associated with inaccurate TB tests, WHO's upcoming recommendations
With "scores of commercial serology tests for tuberculosis ... being sold in high-burden countries," the "WHO is due to release a negative policy recommendation - the first of its kind for the organisation" - after several reviews have "indicated poor performance of these tests," Lancet World Report writes in a piece that documents the health risks associated with a growing number of inaccurate TB tests.
CT scans used in cancer diagnostics can provide valuable clues to preventing heart problems
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's risk for heart problems in the months and years after treatment.
Gallup poll: Most Americans want health law repealed or cut back
A majority of people in the United States say they want ObamaCare to be scaled back or repealed altogether. According to a Gallup poll released Friday, 20 percent support a scale-back of the law, while 32 percent back efforts to repeal it (Shabad, 12/6).
First Edition: June 1, 2011
Kaiser Health News staff writer Phil Galewitz reports: "Trying to spur enrollment in a key new benefit of the 2010 health law, the Obama administration announced today it is slashing premiums for new high-risk insurance plans and no longer requiring applicants to submit a rejection letter from private insurers".
GlaxoSmithKline's Votrient will take significant market share away from Pfizer's Sutent by 2018
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, following its launch and uptake, GlaxoSmithKline's angiogenesis inhibitor Votrient (formerly Armala) will garner sales of $640 million by 2018 and will take significant market share away from Pfizer's Sutent. In 2008, Sutent had accounted for 61 percent of sales in the angiogenesis inhibitor drug class.
› Verified 8 days ago
Speech-Language Pathologists
Chiropractors
Physical Therapists
Occupational Therapists